Thermally activated delayed fluorescence emitters for efficient sensitization of europium(III)

We demonstrate for the first time a unique approach to efficiently sensitize lanthanides(III) using photosensitizer ligands that show thermally activated delayed fluorescence (TADF). TADF ligands have very small singlet (S1) and triplet (T1) excited state energy splitting and S1/T1 energy levels are in optimum energy to the acceptor level of Eu(III) to enable high energy transfer efficiency. The synthesized Eu(III) coordination polymers with TADF ligands showed bright red luminescence with an outstanding sensitization efficiency of 90-94% and Φtot of 79-85% in poly(methyl methacrylate) encapsulated films. This rational approach of efficiently sensitizing lanthanides with TADF ligands demonstrates their great potential for imaging and optical communications applications.

Methyl methacrylate-modified polystyrene microspheres: an effective strategy to enhance the fluorescence of Eu-complexes

The in vitro detection applications of europium complex-doped microspheres mainly rely on strong fluorescence intensity and a well-defined morphology. In this work, using methyl methacrylate-modified polystyrene microspheres has been proven an effective strategy to enhance the fluorescence and morphology of Eu-complexes. The experimental results showed that the modification resulted in the formation of a porous structure within the polystyrene microspheres, enhancing the doping uniformity and facilitating a more significant accumulation of fluorescent molecules. Furthermore, because of their encapsulation ability, microspheres efficiently confine the fluorescent molecules within them. In addition, the nano-scale porous structure endowed the microspheres with enhanced properties without compromising solvent swelling capability, thereby significantly boosting the fluorescence performance of porous PSMMA. In lateral flow immunoassays (LFIAs), PSMMA-Eu microspheres were effectively utilized to detect fentanyl with exceptional sensitivity by capitalizing on these benefits, capable of detecting concentrations as low as 0.10 ng mL-1. This technology has significant potential for rapid point-of-care screening and clinical applications.